Navigation Links
Ten Latin American Scientists Named 2008 Pew Fellows in the Biomedical Sciences
Date:6/12/2008

Program Supports Development of Strong Scientific Capacity in Latin America

WASHINGTON, June 12 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts and the University of California at San Francisco (UCSF) announced today that 10 promising biomedical scientists have been named 2008 Pew Latin American Fellows in the Biomedical Sciences. Funded by Pew through a grant to UCSF, the highly competitive fellowship program offers talented young Latin American scientists $60,000 for a two-year training period. The award is administered by the sponsoring U.S. institution, which supplements the stipend with at least $5,000 a year and also provides medical benefits for the fellow. Following the two year fellowship, the Program will issue an additional $35,000 award to the sponsoring institution to purchase equipment and supplies for the fellow to establish a laboratory in his or her home country.

"Pew's Latin American Fellows Program gives these exemplary scientists the opportunity to further their knowledge, and it promotes exchange and collaboration between researchers in the United States and Latin America," said Rebecca W. Rimel, President and Chief Executive Officer of The Pew Charitable Trusts.

The Pew Latin American Fellows Program in the Biomedical Sciences was launched in 1991 to help develop a cadre of highly trained Latin American scientists who could stimulate and contribute to the growth of quality biomedical science and foster collaboration between scientists in Latin America and the U.S. Since 1991, the Trusts has invested more than $11 million to fund more than 150 fellows, close to 80 percent of whom have returned to their home countries. Applicants from all Central and South American countries are invited to apply, and selection is made by a distinguished national advisory committee chaired by Dr. Torsten N. Wiesel, president emeritus of Rockefeller University and a 1981 Nobel laureate in physiology or medicine.

The 2008 Pew Latin American Fellows in the Biomedical Sciences are:

Fellow Host Laboratory

Mariano Andres Belluscio, Ph.D., Argentina Rutgers University

Katia Carneiro de Paula, Ph.D., Brazil Forsyth Institute/Harvard

School of Dental Medicine

Mauro Javier Cortez Veliz, Ph.D., Brazil Yale University

Maria de la Paz Fernandez, Ph.D., Argentina Harvard University

Nicolas Frankel, Ph.D., Argentina Princeton University

Paula Licona-Limon, Ph.D., Mexico Yale University

Leticia Irene Llarrull, Ph.D., Argentina University of Notre Dame

Cecilia Martin, Ph.D., Mexico Massachusetts General

Hospital

Hector Alex Saka, Ph.D., Argentina Duke University

Marcos Sawada Simoes-Costa, Ph.D., Brazil California Institute of

Technology

For full biographies and information regarding the fellows' research subjects, please visit http://www.pewtrusts.org.

The Pew Charitable Trusts (http://www.pewtrusts.org) is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public and stimulate civic life. We partner with a diverse range of donors, public and private organizations and concerned citizens who share our commitment to fact-based solutions and goal-driven investments to improve society.


'/>"/>
SOURCE Pew Charitable Trusts
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
2. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
3. Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
4. Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
5. Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th
6. White Paper Details New Techniques for Isolating, Identifying Anaerobic Bacteria and Organisms
7. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Paclitaxel and Carboplatin Trial
8. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial
9. Proteon Therapeutics Receives European Patent Covering New Method of Dilating Arteries and Veins
10. UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings
11. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
Breaking Biology Technology:
(Date:6/22/2016)... June 22, 2016   Acuant , ... verification solutions, has partnered with RightCrowd ® ... for Visitor Management, Self-Service Kiosks and Continuous ... that add functional enhancements to existing physical ... and venues with an automated ID verification ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
Breaking Biology News(10 mins):